258 related articles for article (PubMed ID: 33664271)
1. Neuropathy-causing TRPV4 mutations disrupt TRPV4-RhoA interactions and impair neurite extension.
McCray BA; Diehl E; Sullivan JM; Aisenberg WH; Zaccor NW; Lau AR; Rich DJ; Goretzki B; Hellmich UA; Lloyd TE; Sumner CJ
Nat Commun; 2021 Mar; 12(1):1444. PubMed ID: 33664271
[TBL] [Abstract][Full Text] [Related]
2. TRPV4: A trigger of pathological RhoA activation in neurological disease.
Bagnell AM; Sumner CJ; McCray BA
Bioessays; 2022 Jun; 44(6):e2100288. PubMed ID: 35297520
[TBL] [Abstract][Full Text] [Related]
3. TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: a report of three patients.
Cho TJ; Matsumoto K; Fano V; Dai J; Kim OH; Chae JH; Yoo WJ; Tanaka Y; Matsui Y; Takigami I; Monges S; Zabel B; Shimizu K; Nishimura G; Lausch E; Ikegawa S
Am J Med Genet A; 2012 Apr; 158A(4):795-802. PubMed ID: 22419508
[TBL] [Abstract][Full Text] [Related]
4. TRPV4-Rho GTPase complex structures reveal mechanisms of gating and disease.
Kwon DH; Zhang F; McCray BA; Feng S; Kumar M; Sullivan JM; Im W; Sumner CJ; Lee SY
Nat Commun; 2023 Jun; 14(1):3732. PubMed ID: 37353484
[TBL] [Abstract][Full Text] [Related]
5. Calcium and TRPV4 promote metastasis by regulating cytoskeleton through the RhoA/ROCK1 pathway in endometrial cancer.
Li X; Cheng Y; Wang Z; Zhou J; Jia Y; He X; Zhao L; Dong Y; Fan Y; Yang X; Shen B; Wu X; Wang J; Xiong C; Wei L; Li X; Wang J
Cell Death Dis; 2020 Nov; 11(11):1009. PubMed ID: 33230171
[TBL] [Abstract][Full Text] [Related]
6. Structure of human TRPV4 in complex with GTPase RhoA.
Nadezhdin KD; Talyzina IA; Parthasarathy A; Neuberger A; Zhang DX; Sobolevsky AI
Nat Commun; 2023 Jun; 14(1):3733. PubMed ID: 37353478
[TBL] [Abstract][Full Text] [Related]
7. TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function.
Taga A; Peyton MA; Goretzki B; Gallagher TQ; Ritter A; Harper A; Crawford TO; Hellmich UA; Sumner CJ; McCray BA
Ann Clin Transl Neurol; 2022 Mar; 9(3):375-391. PubMed ID: 35170874
[TBL] [Abstract][Full Text] [Related]
8. TRPV4 axonal neuropathy spectrum disorder.
McEntagart M
J Clin Neurosci; 2012 Jul; 19(7):927-33. PubMed ID: 22617546
[TBL] [Abstract][Full Text] [Related]
9. p116Rip targets myosin phosphatase to the actin cytoskeleton and is essential for RhoA/ROCK-regulated neuritogenesis.
Mulder J; Ariaens A; van den Boomen D; Moolenaar WH
Mol Biol Cell; 2004 Dec; 15(12):5516-27. PubMed ID: 15469989
[TBL] [Abstract][Full Text] [Related]
10. Multiubiquitination of TRPV4 reduces channel activity independent of surface localization.
Aisenberg WH; McCray BA; Sullivan JM; Diehl E; DeVine LR; Alevy J; Bagnell AM; Carr P; Donohue JK; Goretzki B; Cole RN; Hellmich UA; Sumner CJ
J Biol Chem; 2022 Apr; 298(4):101826. PubMed ID: 35300980
[TBL] [Abstract][Full Text] [Related]
11. TRPV2 interacts with actin and reorganizes submembranous actin cytoskeleton.
Yadav M; Goswami C
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32985655
[TBL] [Abstract][Full Text] [Related]
12. Compound heterozygous TRPV4 mutations in two siblings with a complex phenotype including severe intellectual disability and neuropathy.
Thibodeau ML; Peters CH; Townsend KN; Shen Y; Hendson G; Adam S; Selby K; Macleod PM; Gershome C; Ruben P; Jones SJM; ; Friedman JM; Gibson WT; Horvath GA
Am J Med Genet A; 2017 Nov; 173(11):3087-3092. PubMed ID: 28898540
[TBL] [Abstract][Full Text] [Related]
13. Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition.
Alabed YZ; Pool M; Ong Tone S; Fournier AE
J Neurosci; 2007 Feb; 27(7):1702-11. PubMed ID: 17301178
[TBL] [Abstract][Full Text] [Related]
14. Axonal neuropathy-associated TRPV4 regulates neurotrophic factor-derived axonal growth.
Jang Y; Jung J; Kim H; Oh J; Jeon JH; Jung S; Kim KT; Cho H; Yang DJ; Kim SM; Kim IB; Song MR; Oh U
J Biol Chem; 2012 Feb; 287(8):6014-24. PubMed ID: 22187434
[TBL] [Abstract][Full Text] [Related]
15. Microtopographical features generated by photopolymerization recruit RhoA/ROCK through TRPV1 to direct cell and neurite growth.
Li S; Tuft BW; Xu L; Polacco MA; Clarke JC; Guymon CA; Hansen MR
Biomaterials; 2015 Jun; 53():95-106. PubMed ID: 25890710
[TBL] [Abstract][Full Text] [Related]
16. TRPV4-pathy, a novel channelopathy affecting diverse systems.
Dai J; Cho TJ; Unger S; Lausch E; Nishimura G; Kim OH; Superti-Furga A; Ikegawa S
J Hum Genet; 2010 Jul; 55(7):400-2. PubMed ID: 20505684
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into TRPV4-Rho GTPase signaling complex function and disease.
Kwon DH; Zhang F; McCray BA; Kumar M; Sullivan JM; Sumner CJ; Lee SY
bioRxiv; 2023 Mar; ():. PubMed ID: 36993766
[TBL] [Abstract][Full Text] [Related]
18. Regulation of RhoA activity by the cellular prion protein.
Kim HJ; Choi HS; Park JH; Kim MJ; Lee HG; Petersen RB; Kim YS; Park JB; Choi EK
Cell Death Dis; 2017 Mar; 8(3):e2668. PubMed ID: 28300846
[TBL] [Abstract][Full Text] [Related]
19. Serine phosphorylation differentially affects RhoA binding to effectors: implications to NGF-induced neurite outgrowth.
Nusser N; Gosmanova E; Makarova N; Fujiwara Y; Yang L; Guo F; Luo Y; Zheng Y; Tigyi G
Cell Signal; 2006 May; 18(5):704-14. PubMed ID: 16109481
[TBL] [Abstract][Full Text] [Related]
20. TRPV4-associated skeletal dysplasias.
Nishimura G; Lausch E; Savarirayan R; Shiba M; Spranger J; Zabel B; Ikegawa S; Superti-Furga A; Unger S
Am J Med Genet C Semin Med Genet; 2012 Aug; 160C(3):190-204. PubMed ID: 22791502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
